Cibisatamab is a monoclonal antibody commercialized by Roche, with a leading Phase II program in Squamous Non-Small Cell Lung Cancer.

Intensive follow-up testing in patients with stage II or III CRC following curative surgery does not appear to improve ...

A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...

Shanghai researchers conduct the Phase I clinical trial of CAR-T therapy with a target on glypican-3, a type of carcinoembryonic antigen, in 2021. [Photo provided to chinadaily.com.cn] After three ...

Background: There are no population-based studies on the prognostic value of the preoperative aminotransferase-to-lymphocyte ratio (AALR) in predicting recurrence and survival in patients with ...